Home / FlashMed


Titolo LETTER TO THE EDITOR - Management of mineral metabolism in haemodialysis patients: need for new strategies
Autore P Esposito1, A Di Benedetto2, T Rampino1, S Stuard3, D Marcelli4, B Canaud4 and A Dal Canton1 -1Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico ‘San Matteo’ and University of Pavia, Pavia, Italy; 2NephroCare Medical Direction, Naples, Italy; 3NephroCare Coordination EMEALA, Bad Homburg, Germany and 4NephroCare EMEALA Medical Board, Bad Homburg, Germany
Referenza European Journal of Clinical Nutrition 2014; doi:10.1038/ejcn.2014.72

We read with great interest the paper by Collinson et al.1 recently published in the European Journal of Clinical Nutrition. The authors investigated the reasons for the high failure rate in preventing hyperphosphataemia in haemodialysis patients (HD). The intriguing conclusion of the study was that none of the expected culprits—for example, drug insufficiency, limited dietary information or advice, and dialysis dose or method—was actually related with the problem. Hence, the suggestion to move to an innovative education-based strategy. Two years ago, NephroCare Medical Direction, a private organization accredited by the Italian Public Health System that delivers dialysis treatment to >2000 patients in Italy, identified control of mineral bone disease (MBD) as the topic of a clinical audit to be performed in all affiliated centres. ………

Data 05.05.2014
Maggiori informazioni   
Lista completa